Galapagos Partners With Gilead on Gamgertamig, Unlocks $500M Cash and Eyes 2027 Registrational Trials [Yahoo! Finance]
Galapagos and Gilead Enter into Binding Agreement to Collaborate on Advancing First in Class T Cell Engager Program for Autoimmune Diseases [Yahoo! Finance]
Galapagos and Gilead Enter into Binding Agreement to Collaborate on Advancing First in Class T Cell Engager Program for Autoimmune Diseases
Galapagos Announces Nomination of Gino Santini to its Board of Directors
Galapagos Publishes 2025 Annual Report and Announces Annual and Extraordinary Shareholders’ Meetings